Protembis Gmbh

Protembis Gmbh company information, Employees & Contact Information

Explore related pages

Related company profiles:

Protembis is an Aachen, Germany based medical device startup. It develops a novel catheter-based filter device for use during cardiac interventions. The device is designed to minimize the risk of stroke and other neurological injury during these interventions – particularly during transcatheter aortic valve replacement procedures (TAVR/ TAVI). The filter blocks embolic debris from entering the blood vessels leading to the brain. The initial safety and feasibility of the ProtEmbo® device has been demonstrated in a first-in-human study in 2017/ 2018. The imaging data of the study suggests that the ProtEmbo® device decreases the risk of brain injury by up to 90%. Protembis has closed an oversubscribed $10M Series A financing round in 2018 and expects to bring its product to market maturity with this round. Therefore the team plans to conduct further clinical studies in heart centers in Europe and the U.S. The ProtEmbo® device is not yet commercially available.

Company Details

Employees
24
Founded
-
Address
Aachen, Nordrhein-Westfalen 52074, De
Phone
+49 (0) 241 9903 3622
Email
in****@****bis.com
Industry
Medical Equipment Manufacturing
NAICS
Medical Equipment and Supplies Manufacturing
Surgical and Medical Instrument Manufacturing
Surgical Appliance and Supplies Manufacturing
Dental Equipment and Supplies Manufacturing
Ophthalmic Goods Manufacturing
Dental Laboratories
HQ
Aachen, Nordrhein-Westfalen
Looking for a particular Protembis Gmbh employee's phone or email?

Protembis Gmbh Questions

News

Protembis Announces Completion of € 30 Million Series B Financing Round and the Addition of Keith D Dawkins MD to the Board of Directors - Business Wire

Protembis Announces Completion of € 30 Million Series B Financing Round and the Addition of Keith D Dawkins MD to the Board of Directors Business Wire

Protembis secures $30m to initiate PROTEMBO IDE trial - Clinical Trials Arena

Protembis secures $30m to initiate PROTEMBO IDE trial Clinical Trials Arena

Protembis Announces First Patient Enrolled in the PROTEMBO IDE Pivotal Trial - VentureBeat

Protembis Announces First Patient Enrolled in the PROTEMBO IDE Pivotal Trial VentureBeat

Protembis enrols first patient for ProtEmbo System trial - Medical Device Network

Protembis enrols first patient for ProtEmbo System trial Medical Device Network

Protembis receives €20M from EIB for cerebral embolic protection system - BioWorld MedTech

Protembis receives €20M from EIB for cerebral embolic protection system BioWorld MedTech

EIB backs Protembis technology with EUR 20 million to protect the brain during cardiac surgery - World Business Outlook

EIB backs Protembis technology with EUR 20 million to protect the brain during cardiac surgery World Business Outlook

Protembis raises $32.6M, adds Shockwave exec to board - MassDevice

Protembis raises $32.6M, adds Shockwave exec to board MassDevice

Mount Sinai neurointerventionist J Mocco joins Protembis board of directors - NeuroNews International

Mount Sinai neurointerventionist J Mocco joins Protembis board of directors NeuroNews International

Protembis Announces Successful First-in-Human Use of ProtEmbo Cerebral Protection System in European Trial - Diagnostic and Interventional Cardiology

Protembis Announces Successful First-in-Human Use of ProtEmbo Cerebral Protection System in European Trial Diagnostic and Interventional Cardiology

German Medtech Protembis Gets €20 Million EIB Backing for Technology to Protect Brain During Heart Treatment - Business Wire

German Medtech Protembis Gets €20 Million EIB Backing for Technology to Protect Brain During Heart Treatment Business Wire

Germany’s Protembis secures €20M from EIB to protect brain during heart treatment - Silicon Canals

Germany’s Protembis secures €20M from EIB to protect brain during heart treatment Silicon Canals

German medtech Protembis raises €20M for brain protection during heart procedures. - Tech.eu

German medtech Protembis raises €20M for brain protection during heart procedures. Tech.eu

Protembis secures FDA approval for PROTEMBO IDE study - Medical Device Network

Protembis secures FDA approval for PROTEMBO IDE study Medical Device Network

Protembis appoints Azin Parhizgar as Board of Directors - World Business Outlook

Protembis appoints Azin Parhizgar as Board of Directors World Business Outlook

Top Protembis Gmbh Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant